Propeller Health

What Propeller Health does

Propeller Health is a digital health platform that provides Bluetooth-enabled smart inhaler sensors, companion mobile applications, and cloud-based analytics to support medication adherence and respiratory disease management for patients with asthma and COPD. The core technology consists of sensors that attach to standard inhalers and automatically capture medication usage, timing, and location data, transmitting it to a mobile app and cloud backend where it is processed to generate personalized feedback, trigger identification, and clinical decision support. The platform is FDA-cleared and supported by peer-reviewed clinical evidence, including an AIR Louisville study published in Health Affairs demonstrating measurable reduction in rescue inhaler use at one year on the platform.

Founded in 2012 in Madison, Wisconsin, Propeller Health was acquired by ResMed (NYSE: RMD) in 2019 and operates as a wholly-owned subsidiary within ResMed's digital health portfolio. The business generates revenue through connected device hardware sales to healthcare providers and patients, subscription-based remote patient monitoring SaaS contracts with health systems and payers, and pharmaceutical partnership arrangements positioned as "beyond-the-pill" digital companion solutions. Distribution is executed through ResMed's enterprise field sales organization, pharmaceutical company partnerships, and payer/PBM networks across the Americas, Europe, and Asia Pacific, rather than through direct-to-consumer channels. The platform is integrated with ResMed's AirView remote monitoring cloud, enabling clinicians to consolidate respiratory medication adherence data alongside sleep and ventilation metrics from ResMed's broader connected care portfolio.

Propeller Health is identified as a key player in the connected drug delivery devices market, which is forecast to grow from $986.91 million in 2024 to $5.08 billion by 2032 at a 23.17% CAGR. The company competes in a market alongside Adherium, Teva Pharmaceuticals, and COHERO Health, and benefits from ResMed's parent-company infrastructure spanning 126+ million lives and 15+ million cloud-connectable devices. Leadership includes co-founder and CTO Greg Tracy, Chief Commercial Officer Chris Hogg, and senior executives covering business development, clinical and medical affairs, finance, and product. Revenue is not separately disclosed because Propeller's financials are consolidated within ResMed's reported figures.

Name

Propeller Health

Legal name

Propeller Health

Website

https://propellerhealth.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

51–100 employees

Short description

Propeller Health provides Bluetooth-enabled smart inhaler sensors, mobile applications, and cloud analytics for medication adherence and respiratory disease management, serving asthma and COPD patients through healthcare providers, payers, and pharmaceutical partners as a ResMed subsidiary.

Ownership category

akta.pro rank

Product category

Digital Respiratory Health / Connected Inhaler Platform

NAICS

Industrial and Commercial Fan and Blower and Air Purification Equipment Manufacturing (333413)

SIC

Industrial & Commercial Fans & Blowers & Air Purifing Equip (3564)

akta.pro primary industry

Nebulizers & Aerosol Drug Delivery Systems (HLAHAIAJ)

akta.pro secondary industry

Asthma & Airway Disease Specialty Care (HLAKAAAC)

Keywords

• Digital respiratory health
• Connected inhaler platform
• Remote patient monitoring
• Medication adherence tracking
• Smart inhaler sensors

Headquarters

HQ city

Madison

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Connected Device Hardware Sales: Sale of smart inhaler sensors and connected devices to healthcare providers, health systems, and patients. Sensors attach to standard inhalers enabling medication tracking functionality.
2. Software as a Service (SaaS) / Remote Patient Monitoring: Subscription-based software services for healthcare providers enabling remote monitoring of patient medication adherence and respiratory outcomes. Revenue generated through enterprise agreements with health systems, payers, and provider networks.
3. Pharmaceutical Partnerships: Partnership arrangements with pharmaceutical companies for co-development of medication adherence solutions and integration with respiratory drug therapies, potentially including licensing and collaborative development arrangements.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Propeller Health operates a connected inhaler platform for asthma and COPD management. It sells Bluetooth-enabled medication sensors that attach to standard inhalers, companion iOS and Android mobile applications, and cloud-based analytics delivered to healthcare providers for remote patient monitoring. The platform is distributed primarily through ResMed's enterprise healthcare professional sales organization and pharmaceutical partnerships.

Product overview

Propeller Health is a digital therapeutics platform focused on respiratory care, specifically smart inhaler technology for asthma and COPD management. The platform consists of a connected sensor device that attaches to inhalers, a mobile application, and cloud-based analytics. As a ResMed subsidiary, Propeller Health operates as part of ResMed's broader digital health ecosystem alongside solutions like AirView for sleep and respiratory care monitoring.

Differentiator

Problem solved

Functional benefit

Products and services

• Propeller Health Connected Inhaler Platform Digital health platform for respiratory care combining Bluetooth-enabled inhaler sensors, companion mobile applications, and cloud-based analytics to track medication usage, support asthma and COPD management, and reduce rescue inhaler use through data-driven patient engagement. Targeted at healthcare providers, health systems, payers, and pharmaceutical partners via ResMed's distribution network.

Quantifiable outcome

• Average reduction in rescue inhaler use at one year on Propeller platform

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• ResMedcoreStrategic or Co-development PartnerPropeller Health was acquired by ResMed (2019) and operates as a wholly-owned subsidiary within ResMed's digital health portfolio. The platform is integrated with ResMed's AirView remote monitoring platform and distributed through ResMed's healthcare professional sales network. Propeller Health benefits from ResMed's global distribution infrastructure, R&D resources, and established relationships with healthcare providers and payers in the sleep and respiratory care markets.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Adherium: Adherium develops connected inhaler sensors and digital respiratory health platforms, directly competing with Propeller Health in smart inhaler technology for asthma and COPD. Both attach sensors to standard inhalers and provide adherence analytics to patients, providers, and pharma partners.
• COHERO Health: COHERO Health offers connected inhaler technology and respiratory disease management platforms, including smart spacers and mobile apps. Like Propeller, it targets healthcare providers and patients with asthma and COPD for adherence tracking and remote monitoring.

Broad incumbents

• Teva Pharmaceutical Industries: Teva is a major respiratory drug manufacturer (ProAir Digihaler) and has been identified alongside Propeller as a key player in connected drug delivery. Teva integrates sensors directly into its inhalers, representing a vertically integrated competitor with first-party digital companions.
• GlaxoSmithKline (GSK): GSK manufactures leading respiratory inhalers (Ellipta, Trelegy) and has invested in digital respiratory solutions and sensor-equipped devices. As a major pharma player in asthma and COPD, GSK competes with Propeller as both a partner and a first-party digital therapeutics developer.
• AstraZeneca: AstraZeneca markets major respiratory brands (Symbicort, Fasenra) and has explored digital inhaler companions and partnerships. Its scale in respiratory therapeutics makes it both a potential channel partner and a competitive threat to Propeller's pharma partnership model.
• Boehringer Ingelheim: Boehringer Ingelheim produces the Respimat inhaler and has invested in digital health initiatives for COPD and asthma. Like other big respiratory pharmas, it is both a potential partner and an integrated competitor in connected respiratory care.
• ResMed: ResMed is Propeller Health's parent company and a leading manufacturer of CPAP and ventilation devices with AirView and myAir platforms. The strategic overlap in remote respiratory monitoring makes ResMed both the primary distribution channel and a strategic comparator for connected respiratory care solutions.
• Philips Respiratory Care: Philips offers connected respiratory care solutions including ventilators, CPAP, and remote patient monitoring through its Care Orchestrator platform. While primarily focused on sleep and hospital ventilation, Philips' connected respiratory ecosystem overlaps with Propeller's provider-facing RPM positioning.

Others

• AptarGroup: AptarGroup is a leading manufacturer of inhaler components and drug delivery devices, and was a lead investor in Propeller's Series C. Aptar provides enabling hardware technology across the respiratory value chain and serves as both an investor/partner and adjacent industry player.

Emerging players

• Voluntis: Voluntis (now part of Insulet) develops digital therapeutics platforms for chronic conditions including respiratory disease. Its Theraxium platform provides connected software-based therapy management, representing an emerging digital-only competitor to Propeller's sensor-plus-software model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/propellerhealth
• Xx.com/PropellerHealth
• Facebookfacebook.com/Asthmapolis

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds7 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Propeller Health